Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 13, 2018

Total Value: $167M (100.0% shares, 0.0% debt)

Holdings (27)

— VIVEVE MEDICAL INC 11.5%
Value $19.13M Shares 3,849,711 Share Price $4.97 Est. Cost/Share $6.92 Unrealized @ Report Date —
— BIOSPECIFICS TECHNOLOGIES 10.0%
Value $16.72M Shares 385,954 Share Price $43.33 Est. Cost/Share $45.54 Unrealized @ Report Date —
— APOLLO ENDOSURGERY INC 8.6%
Value $14.34M Shares 2,560,314 Share Price $5.60 Est. Cost/Share $4.75 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 8.1%
Value $13.45M Shares 885,000 Share Price $15.20 * Est. Cost/Share $14.69 Unrealized @ Report Date +1.0%
ENTA ENANTA PHARMACEUTICALS INC 7.7%
Value $12.82M Shares 218,434 Share Price $58.68 * Est. Cost/Share $30.74 Unrealized @ Report Date +62.9%
— BIODELIVERY SCIENCES INTL 6.4%
Value $10.75M Shares 3,645,491 Share Price $2.95 Est. Cost/Share $2.05 Unrealized @ Report Date —
— RECRO PHARMA INC 5.8%
Value $9.714M Shares 1,050,115 Share Price $9.25 Est. Cost/Share $8.20 Unrealized @ Report Date —
CPIX CUMBERLAND PHARMACEUTICALS 5.8%
Value $9.619M Shares 1,306,911 Share Price $7.36 Est. Cost/Share $5.81 Unrealized @ Report Date +26.6%
VCYT VERACYTE INC 4.8%
Value $8.066M Shares 1,235,147 Share Price $6.53 * Est. Cost/Share $7.51 Unrealized @ Report Date -1.0%
— OPHTHOTECH CORP 4.4%
Value $7.332M Shares 2,350,000 Share Price $3.12 Est. Cost/Share $4.39 Unrealized @ Report Date —
CDNA CAREDX INC 4.0%
Value $6.753M Shares 920,000 Share Price $7.34 * Est. Cost/Share $6.23 Unrealized @ Report Date 0.0%
— NOVELION THERAPEUTICS INC 3.2%
Value $5.288M Shares 1,694,717 Share Price $3.12 Est. Cost/Share $8.59 Unrealized @ Report Date —
— CARDIOME PHARMA CORP 3.0%
Value $4.953M Shares 3,195,692 Share Price $1.55 Est. Cost/Share $2.50 Unrealized @ Report Date —
— CTI BIOPHARMA CORP 2.9%
Value $4.917M Shares 1,834,838 Share Price $2.68 Est. Cost/Share $3.02 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 2.8%
Value $4.735M Shares 3,559,899 Share Price $1.33 Est. Cost/Share $1.33 Unrealized @ Report Date —
— CANCER GENETICS INC 2.0%
Value $3.304M Shares 1,786,063 Share Price $1.85 Est. Cost/Share $1.85 Unrealized @ Report Date —
— MEDICREA INTERNATIONAL 1.5%
Value $2.568M Shares 713,693 Share Price $3.60 Est. Cost/Share $3.60 Unrealized @ Report Date —
— STRONGBRIDGE BIOPHARMA PLC 1.5%
Value $2.496M Shares 344,282 Share Price $7.25 Est. Cost/Share $7.25 Unrealized @ Report Date —
— STEADYMED LTD 1.4%
Value $2.286M Shares 617,725 Share Price $3.70 Est. Cost/Share $3.70 Unrealized @ Report Date —
— EIGER BIOPHARMACEUTICALS INC 1.3%
Value $2.093M Shares 150,000 Share Price $13.95 Est. Cost/Share $13.95 Unrealized @ Report Date —
— NEOS THERAPEUTICS INC 0.9%
Value $1.428M Shares 140,000 Share Price $10.20 Est. Cost/Share $10.20 Unrealized @ Report Date —
— ACER THERAPEUTICS INC 0.8%
Value $1.385M Shares 100,000 Share Price $13.85 Est. Cost/Share $13.85 Unrealized @ Report Date —
— VICAL INC 0.7%
Value $1.238M Shares 676,232 Share Price $1.83 Est. Cost/Share $1.83 Unrealized @ Report Date —
— VERASTEM INC 0.4%
Value $691K Shares 225,000 Share Price $3.07 Est. Cost/Share $3.07 Unrealized @ Report Date —
— AQUINOX PHARMACEUTICALS INC 0.3%
Value $476K Shares 40,500 Share Price $11.75 Est. Cost/Share $11.75 Unrealized @ Report Date —
ADMA ADMA BIOLOGICS INC 0.1%
Value $217K Shares 67,647 Share Price $3.21 * Est. Cost/Share $2.80 Unrealized @ Report Date 0.0%
— AMARIN CORP PLC -ADR 0.0%
Value $70,000 Shares 17,533 Share Price $3.99 Est. Cost/Share $3.99 Unrealized @ Report Date —